Content about Specialty Pharmacy

January 31, 2010
FDA approves expanded use of breast cancer drug

The Food and Drug Administration has given an additional approval to a breast cancer drug...

January 31, 2010
FDA issues safety risk for HIV drug

A rare but serious liver disorder has been reported in some patients taking a drug...

January 31, 2010
FDA seeks budget increase from Obama administration

The Food and Drug Administration hopes to “transform” its oversight of medical product and food...

January 28, 2010
FDA tentatively approves bone cancer generic

The Food and Drug Administration has given tentative approval to a generic version of a...

January 27, 2010
FDA approves labeling update for HIV drug

Tibotec Therapeutics announced Thursday that the Food and Drug Administration has approved a labeling update...

January 27, 2010
URAC gears up for Best Practices Awards

The nation's leading healthcare accreditation and education organization has issued a call for entries for...

January 26, 2010
AmerisourceBergen sees earnings surge across the board

AmerisourceBergen is off to a good start in 2010 with a 44% increase in earnings...

January 24, 2010
Acorda appoints EVP commercial development

The founder of a consulting firm has joined the executive board of Acorda Therapeutics, the...

January 24, 2010
Bayer to halt phase 2 trial of hemophilia treatment

Bayer Schering Pharma will halt a mid-stage clinical trial of an investigational treatment for hemophilia,...

January 24, 2010
BioScrip to acquire Critical Homecare Solutions

BioScrip will acquire a home infusion services provider that specializes in chronic and acute medical...

January 21, 2010
FDA approves Ampyra

The Food and Drug Administration has approved a new drug for improving walking ability in...

January 20, 2010
Clinical trial finds Novartis drug reduces progression of MS

An investigational drug for treating multiple sclerosis reduced progression of disability by more than 30%,...

January 20, 2010
Ipsen, Inspiration Pharmaceuticals to develop hemophilia franchise

Despite its rarity, occurring in 1-in-5,000 to 1-in-25,000 male births, hemophilia can be a debilitating...

January 20, 2010
Teva receives tentative approval for breast cancer drug

The Food and Drug Administration has given tentative approval to Teva Pharmaceutical Industries for its...

January 18, 2010
Decision Resources acquires BioTrends

One of the world's leading research and advisory firms focusing on healthcare insights and analysis...

January 18, 2010
FDA extends review of lung cancer treatment

The Food and Drug Administration has extended its review period for a lung cancer drug...

January 18, 2010
Walgreens receives URAC accreditation for specialty pharmacy

Walgreens has been awarded accreditation from URAC, a Washington, D.C.-based healthcare accrediting organization that establishes...

January 17, 2010
MedPro Rx offering scholarships to students with bleeding disorders

Prospective college students living with bleeding disorders have a chance to receive a scholarship from...

January 13, 2010
Hy-Vee, specialty pharmacy Amber form Hy-Vee Pharmacy Solutions

Retail pharmacy Hy-Vee and specialty pharmacy Amber earlier this week announced the two companies would...

January 12, 2010
Researchers find key to chemotherapy resistance in lung cancer patients

Researchers in Arizona have found a way to predict which patients might be resistant to...

January 11, 2010
Biogen Idec seeks approval in Canada, European Union for MS drug

Biogen Idec hopes to win approval for a multiple sclerosis drug in Canada and the...

January 11, 2010
Galapagos, Roche to develop COPD treatments

A Belgian biotech company plans to work with Swiss drug maker Roche to develop treatments...

January 6, 2010
Pfizer to develop cancer drug with Debiopharm

Two drug makers have entered an agreement to develop a drug designed to treat melanoma....

January 5, 2010
Adherence to HIV therapy may cut healthcare costs, study finds

Increased adherence of HIV therapy may be cost-effective, according to a new study....

January 5, 2010
Decision Resources: Onglyza sales will boast more than $1 billion

A research firm for pharmaceutical and healthcare issues projected sales of more than $1 billion...